EurekAlert!7 个月
Anti-inflammatory drug celecoxib could reduce risk of colon cancer recurrence for a subset ...
The study, highlighting a potential breakthrough in personalized cancer treatment, was led by clinical investigators at Dana-Farber Cancer Institute and Brigham and Women’s Hospital and ...